Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander T Cohen

Showing results (11-20 of 227) with videos related to

Pageof 23
Sort By:
Seminars in Respiratory and Critical Care Medicine|February 28, 2008
Venous thromboembolism prophylaxis for the medical patient: where do we stand?Yshai Yavin, Alexander T Cohen
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 29, 2019
Rivaroxaban and the EINSTEIN clinical trial programmeAlexander T Cohen, Rupert Bauersachs
Thrombosis and Haemostasis|February 29, 2012
The use of rivaroxaban for short- and long-term treatment of venous thromboembolismAlexander T Cohen, Mark Dobromirski
Research and Practice in Thrombosis and Haemostasis|March 27, 2023
Limitations of venous thromboembolism risk assessment models in medical patients: Response to "Unmet definitions in thromboprophylaxis for hospitalized medical patients: An appraisal for the need of recommendation"Chaozer Er, Alexander T Cohen
Thrombosis and Haemostasis|March 27, 2015
VTE primary prevention, including hospitalised medical and orthopaedic surgical patientsSerena Granziera, Alexander T Cohen
Blood|June 19, 2012
How I manage venous thromboembolism risk in hospitalized medical patientsMark Dobromirski, Alexander T Cohen
Annals of Internal Medicine|October 2, 2013
Aspirin versus low-molecular-weight heparin after total hip arthroplastySerena Granziera, Alexander T Cohen
Evidence-Based Medicine|May 20, 2014
Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapySerena Granziera, Alexander T Cohen
Thrombosis and Haemostasis|June 19, 2015
Anticoagulation strategies for venous thromboembolism: moving towards a personalised approachStephen A Black, Alexander T Cohen
Hematology. American Society of Hematology. Education Program|December 7, 2019
Is there a role for low-dose DOACs as prophylaxis?Alexander T Cohen, Beverley J Hunt
Pageof 23

Showing results (11-20 of 227) with videos related to

Sort By:
Pageof 23
Seminars in Respiratory and Critical Care Medicine|February 28, 2008
Venous thromboembolism prophylaxis for the medical patient: where do we stand?Yshai Yavin, Alexander T Cohen
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 29, 2019
Rivaroxaban and the EINSTEIN clinical trial programmeAlexander T Cohen, Rupert Bauersachs
Thrombosis and Haemostasis|February 29, 2012
The use of rivaroxaban for short- and long-term treatment of venous thromboembolismAlexander T Cohen, Mark Dobromirski
Research and Practice in Thrombosis and Haemostasis|March 27, 2023
Limitations of venous thromboembolism risk assessment models in medical patients: Response to "Unmet definitions in thromboprophylaxis for hospitalized medical patients: An appraisal for the need of recommendation"Chaozer Er, Alexander T Cohen
Thrombosis and Haemostasis|March 27, 2015
VTE primary prevention, including hospitalised medical and orthopaedic surgical patientsSerena Granziera, Alexander T Cohen
Blood|June 19, 2012
How I manage venous thromboembolism risk in hospitalized medical patientsMark Dobromirski, Alexander T Cohen
Annals of Internal Medicine|October 2, 2013
Aspirin versus low-molecular-weight heparin after total hip arthroplastySerena Granziera, Alexander T Cohen
Evidence-Based Medicine|May 20, 2014
Evidence suggests dabigatran is an effective and safe treatment for patients with VTE requiring early parenteral therapySerena Granziera, Alexander T Cohen
Thrombosis and Haemostasis|June 19, 2015
Anticoagulation strategies for venous thromboembolism: moving towards a personalised approachStephen A Black, Alexander T Cohen
Hematology. American Society of Hematology. Education Program|December 7, 2019
Is there a role for low-dose DOACs as prophylaxis?Alexander T Cohen, Beverley J Hunt
Pageof 23